Vivoryon Therapeutics NV
AEX:VVY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vivoryon Therapeutics NV
AEX:VVY
|
DE |
|
Basf Se
OTC:BFFAF
|
DE |
|
N
|
NOW Inc
BMV:DNOW
|
US |
|
APA Corp (US)
F:2S3
|
US |
|
F
|
Ford Motor Co
DUS:FMC1
|
US |
|
D
|
DaVita Inc
F:TRL
|
US |
|
Perpetua Resources Corp
F:9MIB
|
US |
|
I
|
Industrial and Commercial Bank of China Ltd
DUS:ICK
|
CN |
|
K
|
Kronos Worldwide Inc
XMUN:K1W
|
US |
|
W
|
Weichai Power Co Ltd
F:WI4
|
CN |
|
G
|
Gentili Mosconi SpA
MIL:GM
|
IT |
|
Stroeer SE & Co KgaA
OTC:SOTDF
|
DE |
|
HIAG Immobilien Holding AG
F:0HG
|
CH |
|
K
|
Kawasaki Heavy Industries Ltd
SWB:KHE
|
JP |
|
D
|
Diamondrock Hospitality Co
F:HBO
|
US |
|
I
|
Intesa Sanpaolo SpA
DUS:IES
|
IT |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
US |
|
Liberty Latin America Ltd
F:1LL
|
US |
|
P
|
Pernod Ricard SA
SWB:PER
|
FR |
|
Nippon Prologis REIT Inc
TSE:3283
|
JP |
|
Gap Inc
NYSE:GAP
|
US |
|
I
|
Interpublic Group of Companies Inc
XMUN:IPG
|
US |
|
M
|
Meritage Homes Corp
F:MEY
|
US |
|
Biohit Oyj
LSE:0DRP
|
FI |
Bankruptcy Probability
Vivoryon Therapeutics NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vivoryon Therapeutics NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Vivoryon Therapeutics NV
AEX:VVY
|
31.7m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vivoryon Therapeutics NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vivoryon Therapeutics NV has total debt of 11k EUR. This includes both short-term (0 EUR) and long-term (11k EUR) debt.
You can find a full breakdown on its Balance Sheet.
